Kei Motonaga

Title: Kei Motonaga: Innovator in Pharmaceutical Development

Introduction

Kei Motonaga is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work focuses on creating effective treatments for serious medical conditions, showcasing his dedication to improving patient outcomes.

Latest Patents

Motonaga holds a patent for a tablet containing a composite with cyclodextrin. This tablet comprises N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea or a pharmaceutically acceptable salt thereof. This formulation is designed as a medicament for treating acute myeloid leukemia (AML). The tablet is characterized by a composite of the active drug and hydroxypropyl-β-cyclodextrin in a specific ratio ranging from 1:8 to 1:20.

Career Highlights

Motonaga is associated with Ambit Biosciences Corporation, where he contributes his expertise in drug development. His work at the company emphasizes the importance of innovative solutions in the pharmaceutical industry. His dedication to research and development has positioned him as a key figure in advancing treatments for complex diseases.

Conclusion

Kei Motonaga's contributions to pharmaceutical innovations, particularly in the treatment of acute myeloid leukemia, highlight his role as a significant inventor in the field. His patent reflects a commitment to improving healthcare through scientific advancements.